Cargando…
A lipidomic view of SARS-CoV-2
The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has caused huge social and economic losses. A growing number of investigators are focusing on understanding the interaction of SARS-CoV-2 with host cellular processes to find therapeutic...
Autores principales: | Ebrahimi, Kourosh H., McCullagh, James S.O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350433/ https://www.ncbi.nlm.nih.gov/pubmed/34313294 http://dx.doi.org/10.1042/BSR20210953 |
Ejemplares similares
-
Neutralizing SARS-CoV-2
por: Poeschla, Eric
Publicado: (2020) -
Taking on SARS-CoV-2
por: Kučan Brlić, Paola, et al.
Publicado: (2022) -
SARS-CoV-2 uses CD4 to infect T helper lymphocytes
por: Brunetti, Natalia S, et al.
Publicado: (2023) -
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
por: Grobben, Marloes, et al.
Publicado: (2021) -
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)